genetic testing for autism spectrum disorder

Original articles published in peer-reviewed journals were screened in a two-step process. A very early diagnosis uses molecular genetic tests, which are also offered commercially.OBJECTIVE: Systematic review of the economic impact of genetic tests in ASD.METHODS: We performed a systematic search of databases Pubmed, Medline, Cochrane, Econlit and the NHS Center for Reviews and Dissemination for articles in English and German from Januto December 31, 2015. The earlier the diagnosis is made, the higher are the chances of obtaining relief of symptoms. There is a clear lack in research for EE of genetic tests.Ībstract = 'BACKGROUND: Autism Spectrum Disorder (ASD) is a highly heritable neural development disorder characterized by social impairment. Cost-effectiveness analyses for genetic diagnostic tests for ASD are urgently required. The outcomes used in the EE of the genetic tests were heterogeneous, and results were generally not comparable.ĬONCLUSION: There is no evidence for cost-effectiveness of any genetic diagnostic test for ASD, although such genetic tests are available commercially. However, not a single EE of genetic tests has been found for ASD. RESULTS: We identified 185 EE of genetic tests for various diseases. Second, we searched for any economic evaluation (EE) of genetic tests. First, we focused our search on economic evaluations of genetic tests for ASD. METHODS: We performed a systematic search of databases Pubmed, Medline, Cochrane, Econlit and the NHS Center for Reviews and Dissemination for articles in English and German from Januto December 31, 2015.

OBJECTIVE: Systematic review of the economic impact of genetic tests in ASD. A very early diagnosis uses molecular genetic tests, which are also offered commercially. BACKGROUND: Autism Spectrum Disorder (ASD) is a highly heritable neural development disorder characterized by social impairment.

Genetic testing for autism spectrum disorder